![Jennifer Peppe](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jennifer Peppe
Fondateur chez
IMAGO BIOSCIENCES, INC.
Profil
Jennifer Peppe is the founder of Imago BioSciences, Inc. which is founded in 2012, where she currently holds the title of Senior Vice President-Clinical Operations.
She previously worked as an Associate Director at Genzyme Corp.
and as a Senior Director-Clinical Operations at FerroKin BioSciences, Inc. from 2010 to 2012.
Ms. Peppe received her undergraduate degree from Smith College.
Postes actifs de Jennifer Peppe
| Sociétés | Poste | Début |
|---|---|---|
| IMAGO BIOSCIENCES, INC. | Fondateur | 29/03/2012 |
Anciens postes connus de Jennifer Peppe
| Sociétés | Poste | Fin |
|---|---|---|
FerroKin BioSciences, Inc.
 FerroKin BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Offers iron chelator for the treatment of iron-overload in patients | Directeur Technique/Scientifique/R&D | 01/01/2012 |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Corporate Officer/Principal | - |
Formation de Jennifer Peppe
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
7
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Smith College
 Smith College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
FerroKin BioSciences, Inc.
FerroKin BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Offers iron chelator for the treatment of iron-overload in patients | Health Technology |
Imago BioSciences, Inc.
 Imago BioSciences, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops medicines for the treatment of myeloproliferative neoplasms and bone marrow diseases | Health Technology |
